Artio Medical Receives FDA Clearance for Solus Gold Embolization Device
Company prepares for US commercial launch.
Stay updated with breaking news from Solus Gold Embolization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company prepares for US commercial launch.
/PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology...
/PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart...
The round was led by existing investors Nathaniel and Sarah Hagedorn. The company intends to use the funds to complete the first-in-human clinical study of its Amplifi ™ Vein Dilation System and prepare for commercialization of its Solus Gold ™ Embolization Device. Led by F. Nicholas Franano, MD, President and CEO, Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascul...
Artio Medical Closes Tranche of $12 Million in Series A Financing Company to accelerate clinical testing and prepare for commercialization of its broad portfolio of products News provided by Share this article Share this article PRAIRIE VILLAGE, Kan., April 29, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today the closing of an additional $12 million tranche of Series A financing, bringing the total to $46 million. Led by existing investors Nathaniel and Sa...